Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
Ceesay Abraham | Director | C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON | /s/ Abraham Ceesay | 2025-06-03 | 0001722140 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRL | Common Stock | Award | $128K | +946 | $135.04 | 946 | Jun 2, 2025 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRL | Stock Options (Right to Buy) | Award | $281K | +2.08K | $135.04 | 2.08K | Jun 2, 2025 | Common Stock | 2.08K | $135.04 | Direct | F2 |
Id | Content |
---|---|
F1 | The unvested restricted stock units vest upon the earlier of 6/2/2026 or the business day prior to the Company's next annual meeting of shareholders. |
F2 | The stock options become exercisable upon the earlier of 6/2/2026 or the business day prior to the Company's next annual meeting of shareholders. |